MARKET

GNNSF

GNNSF

Genscript Biotec
OTCPK
4.500
NaN%
Closed 09:30 11/19 EST
OPEN
--
PREV CLOSE
4.500
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
5.83
52 WEEK LOW
1.400
MARKET CAP
10.28B
P/E (TTM)
-15.4110
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GNNSF last week (1109-1113)?
Weekly Report · 4d ago
Morgan Stanley Sticks to Their Buy Rating for Genscript Biotech (GNNSF)
TipRanks · 6d ago
Genscript Discloses Legend Biotech Third-Quarter 2026 Results
TipRanks · 11/10 12:39
Weekly Report: what happened at GNNSF last week (1102-1106)?
Weekly Report · 11/09 10:14
Legend Biotech to Present Cell-Therapy Data at ASH 2026
TipRanks · 11/04 23:42
GenScript Clarifies Trading-Counter Change Amid Share-Price Volatility
TipRanks · 11/03 11:09
Weekly Report: what happened at GNNSF last week (1026-1030)?
Weekly Report · 11/02 10:13
GenScript Biotech Reports Death of Company Secretary
TipRanks · 11/02 09:08
More
About GNNSF
Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.

Webull offers Genscript Biotech Corp stock information, including OTCPK: GNNSF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNNSF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNNSF stock methods without spending real money on the virtual paper trading platform.